Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 25 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 10138277

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  2. US 10138271

    Native and agonist CTL epitopes of the MUC1 tumor antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  3. US 10130594

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  4. US 10131659

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  5. US 10130593

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  6. US 10125172

    Conformationally stabilized RSV pre-fusion F proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  7. US 10125112

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  8. US 10117947

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  9. US 10119172

    Methods and reagents for detecting ebola virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  10. US 10117942

    Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  11. US 10118948

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  12. US 10111927

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  13. US 10113183

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  14. US 10106620

    Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  15. US 10100346

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  16. US 10094836

    SLCO1B3 genotype

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  17. US 10087148

    Quinazolines as biogenic amine transport modulators

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  18. US 10087211

    Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  19. US 10087230

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  20. US 10076535

    Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  21. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  22. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  23. US 10072078

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  24. US 10072070

    Potent anti-influenza A neuraminidase subtype N1 antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.